US Patent

US8440854 — Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17

Formulation · Assigned to Reata Pharmaceuticals Inc · Expires 2029-04-20 · 3y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects novel oleanolic acid derivatives and their use in pharmaceutical compositions, kits, and articles of manufacture.

USPTO Abstract

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US8440854
Jurisdiction
US
Classification
Formulation
Expires
2029-04-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Reata Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.